DeFrancesco Lisa
SEC insider (Form 3/4/5 filer). CIK 0001846325. SVP, IR and Corp Comm at LEXICON PHARMACEUTICALS, INC. (LXRX). 9 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in SPRING, TX.
Companies DeFrancesco Lisa has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, SVP, IR and Corp Comm
DeFrancesco Lisa
CIK: 0001846325
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect74.6K shares at avg. $1.47$110K - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect128.2K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect24.7K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
257.5K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
386.3K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect9.1K shares at avg. $0.67$6K - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect24.7K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
576.9K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
384.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 74,572 | $1.47 | $109,621 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 128,190 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 24,674 | - | $0 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 257,530 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 386,300 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 9,096 | $0.67 | $6,094 | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 24,673 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 576,850 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 384,570 | - | - | Direct |
1-9 of 9 transactions